Close

Let’s Celebrate CBD

CBD might not get you high, but it can definitely take you higher. 

 

With an assist from some national calendar folk, the first National CBD Day (August 8) took place in 2018 and has grown in popularity each year since. The more famous canna-centric days, 420 and 710, tend to focus more on elevation, but National CBD Day is about education. Or at least that’s how we’re choosing to celebrate CBD this year.  

 

Cannabidiol (CBD) is a naturally occurring compound found in cannabis plants. While the term CBD only entered the mainstream lexicon in the past decade, researchers have been studying it all the way back to at least 1940. That’s when Roger Adams & Co. published “Structure of Cannabidiol” (Journal of the American Chemical Society) that analyzed oil from wild hemp growing freely in Minnesota. A few decades later, the legendary Dr. Raphael Mechoulam made further breakthroughs on CBD and other cannabinoids that set the foundation for modern cannabis research. 

 

So, how does CBD work? Each person has a cannabinoid receptor system in his or her body, and that system includes two main types of receptors (CB1 and CB2) that help the body maintain a stable biological environment. Chemicals bind to receptors and typically produce some type of chemical or tissue response, and cannabinoids like THC act directly on these receptors. CBD does not. Rather, it stimulates the production of compounds produced within the body (endocannabinoids) that do, and CBD does bind to different receptors associated with pain perception, mood and inflammation. Those who want a more detailed explanation can check the clinical study “Cannabinoid pharmacology: the first 66 years,” but the gist is that CBD produces biochemical reactions in the body that might offer health, wellness and even medical benefits. 

 

Less than two months before the inaugural National CBD Day, the Food & Drug Administration (FDA) approved the first CBD-based medication, Epidiolex, which treats certain types of pediatric seizures. The FDA has historically demonstrated an anti-cannabis and anti-CBD bias, but it has approved other clinical studies recently, including the use of CBD to treat cardiovascular complications in COVID-19 patients. 

 

Still, there might be a lot more to come. Preliminary studies suggest CBD might help with issues like chronic pain, anxiety, inflammation, post-traumatic stress disorder (PTSD), opiate withdrawal and neurodegenerative disorders, among others. A 2013 study (The British Journal of Clinical Pharmacology) even suggested CBD might have anticancer properties that interfere with “tumor neovascularization, cancer cell migration, adhesion, invasion and metastasization.” Even on a lifestyle level, anecdotal evidence suggests CBD might elevate basic health and wellness. 

 

FDA-backed studies will eventually provide more clarity and specifics, but the wait requires us to exercise patience, which, ironically, the calming effects of CBD might help promote.

 

CBD is a big part of what we do here at Hollister. We’ve read studies and heard congressional testimony that suggests CBD might help military veterans deal with PTSD, so we partnered with Allied Corp. on Tactical Relief. Many of us also own pets that we consider part of our extended family, so we created Purity Petibles with CBD to provide dogs and cats with potential relief from pain and inflammation. More CBD-based products will debut soon. 

 

Hollister Cannabis Co. proudly celebrates cannabidiol on National CBD Day, but we’re also absolutely committed to celebrating and promoting CBD wellness every day of the year. 

 

#NationalCBDDay!